The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


200 Milligram Tablets

Menarini International Operations Luxembourg S.A.EU/1/13/841/008-010

Main Information

Trade NameSPEDRA
Active SubstancesAVANAFIL
Strength200 Milligram
Dosage FormTablets
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberEU/1/13/841/008-010

Group Information

ATC CodeG04BE10 Drugs used in erectile dysfunction


Licence Issued21/06/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back